FGFR1 and neoplasm: In the case of FGFR1 driven neoplasms, mechanisms of resistance that have been suggested in animal studies can be monitored during the course of standard ant-FGFR1 treatment to possibly detect emergence of resistant clones, although it cannot be excluded that novel mechanisms may also arise.